Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial hyperaldosteronism.

M Stowasser1, R D Gordon

  • 1Hypertension Unit, University Department of Medicine, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4120, Brisbane, Australia. m.stowasser@mailbox.uq.edu.au

The Journal of Steroid Biochemistry and Molecular Biology
|October 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Content and delivery preferences for information to support the management of high blood pressure.

Journal of human hypertension·2022
Same author

ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II).

Journal of human hypertension·2017
Same author

Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea.

Journal of human hypertension·2017
Same author

JHH change in leadership.

Journal of human hypertension·2015
Same author

Waiting a few extra minutes before measuring blood pressure has potentially important clinical and research ramifications.

Journal of human hypertension·2013
Same author

Salt, aldosterone and hypertension.

Journal of human hypertension·2012
Same journal

L-Arginine Improves Prenatal and Pre-pubertal Codeine-Induced Steroidogenesis Deregulation by Suppressing Oxidative Stress-Dependent Signaling in Male Wistar Rats.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

Discovery of 17-imidazo[1,2-a]pyridinyl-3α-hydroxy-5α-androstanes (17IPAs) as novel potent positive allosteric modulators of the GABA<sub>A</sub> receptor: Synthesis, in vitro and in silico studies.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

Androgen receptor as therapeutic indicator for LAR-positive triple-negative breast cancer: Preclinical and clinical assessment.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

The 24,25(OH)<sub>2</sub>D<sub>3</sub>-TLCD3B signaling complex and reproductive function in mice and men.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

Testosterone and epitestosterone differentially regulate UDP-glucuronosyltransferases (UGT) activity.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

Interferon-gamma-inducible protein-10 is associated to increased primary bile acids and fibrosis in primary sclerosing cholangitis.

The Journal of steroid biochemistry and molecular biology·2026
See all related articles

Primary aldosteronism (PAL) is common, often with normal potassium. Glucocorticoid-remediable PAL (FH-I) involves a hybrid gene, requiring lower glucocorticoid doses. Familial hyperaldosteronism type II (FH-II) links to chromosome 7.

Area of Science:

  • Endocrinology
  • Genetics
  • Hypertension Research

Background:

  • Primary aldosteronism (PAL) is increasingly recognized, affecting more patients than previously thought, often without high potassium levels.
  • Familial forms of PAL, particularly FH-I and FH-II, offer insights into the condition's diverse clinical, biochemical, and molecular characteristics.

Purpose of the Study:

  • To investigate the genetic basis and clinical manifestations of familial hyperaldosteronism types I and II.
  • To refine understanding of glucocorticoid treatment efficacy in FH-I and identify genetic loci for FH-II.

Main Methods:

  • Genetic testing for diagnosis of FH-I.
  • Analysis of aldosterone/PRA/cortisol 'day-curves' in FH-I patients.
  • Linkage analysis and genome-wide search to identify genetic loci for FH-II.

Related Experiment Videos

Main Results:

  • FH-I is caused by a hybrid CYP11B1/CYP11B2 gene, with hypertension severity linked to various factors including gene crossover position.
  • Effective hypertension management in FH-I requires only partial ACTH suppression, necessitating lower glucocorticoid doses than previously recommended.
  • FH-II is not glucocorticoid-remediable and shows linkage to a locus on chromosome 7, distinct from known genes like CYP11B2, AT1, or MEN1.

Conclusions:

  • Elucidating the genetic underpinnings of PAL, including FH-I and FH-II, is crucial for earlier diagnosis and targeted treatment of hypertension.
  • Understanding the molecular mechanisms of familial aldosteronism can lead to the identification of novel therapeutic targets for various forms of hypertension.